Stockholm – October 07, 2026 -- SciBase Holding AB has resolved on a set-off share issue of 60,000 new shares to Bergs Securities AB, settling part of the guarantee compensation owed for underwriting the company's recently completed rights issue.

Stockholm – October 01, 2026 -- SciBase Holding AB has closed its rights issue fully subscribed, raising approximately SEK 57.5 million before issue costs to fund continued commercialisation of its Nevisense melanoma-diagnostics platform in the United States.

Stockholm – September 25, 2026 -- SciBase Holding AB's SEK 57.5 million rights issue is now fully covered after Bergs Securities AB confirmed a binding guarantee commitment of approximately SEK 24.2 million, equal to 42 percent of the offering.